Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease
Titel:
Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease
Auteur:
Olson, Katherine E. Namminga, Krista L. Lu, Yaman Schwab, Aaron D. Thurston, Mackenzie J. Abdelmoaty, Mai M. Kumar, Vikas Wojtkiewicz, Melinda Obaro, Helen Santamaria, Pamela Mosley, R. Lee Gendelman, Howard E.